FIBROGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.1 USD | -7.56% |
|
-8.33% | +24.11% |
| Jun. 04 | Top Premarket Gainers | MT |
| Jun. 03 | FibroGen Investigational New Drug Application for Cancer Treatment Accepted by FDA; Regeneron Selected as Supplier | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.230 | 2.730 | 2.730 |
| Spread/Res. | -10.57% | -59.71% | -59.71% |
| Spread/Supp. | +3.77% | +92.64% | +189.40% |
| Support | 1.060 | 0.5710 | 0.3801 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- FGEN Stock
- Charts FibroGen, Inc.
